![]() |
市場調查報告書
商品編碼
2159465
鼻淚管支架市場規模、佔有率和成長分析:按產品類型、材料、應用、最終用戶和地區分類-2026-2033年產業預測Nasolacrimal Stents Market Size, Share, and Growth Analysis, By Product Type (Bicanalicular Stents, Monocanalicular Stents), By Material (Silicone, Polyurethane), By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球鼻淚管支架市場價值為 1.285 億美元,預計到 2033 年將從 2025 年的 1.3595 億美元成長至 2.1344 億美元,預測期(2026-2033 年)複合年成長率為 5.8%。
全球鼻淚管支架市場正經歷顯著的變革,尤其是在老年族群中鼻淚管阻塞發生率不斷上升的情況下。這些裝置在術後維持淚液引流方面發揮著至關重要的作用。雖然傳統支架主要採用矽膠管,但目前正逐漸轉向使用先進的生物材料,包括自固位支架和藥物釋放型支架,以最大限度地減少術後併發症。影像技術和微創植入技術的引入加速了這些產品的普及,從而縮短了手術時間並降低了併發症率。此外,無需手術取出即可自行溶解的生物可分解支架也備受關注。人工智慧驅動的自動化技術透過最佳化設計、製造和品管,進一步推動了市場發展,在改善成本控制和患者療效的同時,也促進了創新。製造商正積極拓展研發活動,以掌握這些新的機會。
全球鼻淚管支架市場成長要素
眼科醫師在鼻淚管置入術微創置入技術方面的專業水準不斷提高,推動了該技術在臨床上的廣泛應用,並使其在各種治療環境中得到更廣泛的認可。隨著醫療專業人員對此手術的有效性和安全性信心的增強,轉診流程正在簡化,醫院也開始將支架解決方案納入日常診療流程。這種應用的激增帶動了對各種支架產品的需求,促進了創新和整體市場成長。此外,患者對微創治療的偏好日益增強,也促使手術量增加,而持續的培訓計畫則提升了該領域新興醫療專業人員的技能。
全球鼻淚管支架市場限制因素
鼻淚管支架市場面臨許多監管挑戰,且因地區而異,產品上市前需要進行全面的臨床檢驗和詳盡的文件記錄。嚴格的安全性和有效性要求迫使製造商投入大量時間和資源進行臨床試驗和合規工作,這可能導致產品上市延遲和研發成本增加。此外,醫療設備分類法規的波動也為尋求核准的企業帶來不確定性,阻礙了新產品的快速上市。因此,這些監管障礙限制了市場擴張,阻礙了創新技術惠及更廣泛用戶群的速度。
鼻淚管支架市場的全球趨勢
全球鼻淚管支架市場正經歷著微創技術的顯著轉變,這主要得益於人們對提升病患舒適度、縮短手術時間和降低併發症風險的日益重視。這種轉變促使製造商研發和生產更薄、更柔軟性的支架,以便透過微創切口輕鬆植入。因此,這一發展擴大了適用患者群體,並有助於更積極地管理慢性溢淚症。隨著已開發國家和開發中國家的醫療體系逐步採用這些先進技術,預計對鼻淚管支架的需求將持續成長,從而促進全球不同患者群體視覺健康的長期改善。
Global Nasolacrimal Stents Market size was valued at USD 128.5 Million in 2024 and is poised to grow from USD 135.95 Million in 2025 to USD 213.44 Million by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).
The global nasolacrimal stents market is evolving significantly, driven by the increasing prevalence of nasolacrimal duct obstruction, particularly among the aging population. These devices play a crucial role in maintaining tear drainage after surgical procedures. Traditional reliance on silicone tubes is being replaced by advanced biomaterials, including self-retaining, drug-eluting stents that minimize postoperative complications. The integration of imaging techniques and minimally invasive delivery methods has accelerated adoption, leading to shorter procedure times and lower complication rates. Additionally, biodegradable stents that dissolve without the need for removal surgeries are gaining traction. AI-driven automation is further enhancing the market by optimizing design, manufacturing, and quality control, promoting innovation while managing costs and improving patient outcomes. Manufacturers are actively expanding R&D endeavors to capitalize on these emerging opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nasolacrimal Stents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Nasolacrimal Stents Market Segments Analysis
Global nasolacrimal stents market is segmented by product type, material, application, end user and region. Based on product type, the market is segmented into Bicanalicular Stents, Monocanalicular Stents, Monocanalicular Stents with Punctal Plugs and Other Nasolacrimal Stents. Based on material, the market is segmented into Silicone, Polyurethane and Other Materials. Based on application, the market is segmented into Nasolacrimal Duct Obstruction, Canalicular Laceration, Dacryocystorhinostomy and Other Applications. Based on end user, the market is segmented into Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centers and Other Healthcare Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Nasolacrimal Stents Market
The increasing expertise of ophthalmic surgeons in minimally invasive nasolacrimal stenting techniques is enhancing clinical acceptance, prompting wider application in various treatment facilities. As healthcare professionals become more assured of the procedures' effectiveness and safety, referral processes are simplified, leading hospitals to integrate stent solutions into their routine care practices. This surge in procedural adoption boosts demand for a diverse array of stent products, promoting innovation and overall market growth. Furthermore, the rising preference among patients for less invasive treatment options is contributing to higher procedure volumes, while continuous training programs help cultivate skills among emerging practitioners in the field.
Restraints in the Global Nasolacrimal Stents Market
The nasolacrimal stents market encounters significant regulatory challenges that differ by region, necessitating thorough clinical validation and extensive documentation prior to product introduction. The stringent safety and efficacy requirements impose substantial time and resource investments on manufacturers as they navigate trials and compliance measures, resulting in potential delays in market launch and higher development expenditures. Additionally, shifting regulations surrounding medical device classification create uncertainty for companies aiming for approval, which can hinder the swift introduction of new products. Consequently, these regulatory barriers constrain market expansion by restricting the pace at which innovative technologies can reach a broader audience.
Market Trends of the Global Nasolacrimal Stents Market
The global nasolacrimal stents market is witnessing a significant trend towards minimally invasive techniques, driven by a focus on enhancing patient comfort, decreasing surgical duration, and minimizing complication risks. This shift has led manufacturers to innovate and produce thinner, more flexible stents that can be easily delivered via micro-incision methods. Consequently, this evolution broadens the patient base eligible for treatment and promotes proactive management of chronic epiphora. As healthcare systems, both established and developing, adopt these advancements, the demand for nasolacrimal stents is expected to grow, supporting improved long-term visual health outcomes for a diverse range of patients globally.